HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

WYE 125132

an antineoplastic agent that inhibits mTORC1 and mTORC2
Also Known As:
WYE-125132; WYE-132; WYE125132
Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Toral-Barza, Lourdes: 3 articles (01/2012 - 01/2010)
2. Yu, Ker: 3 articles (01/2012 - 01/2010)
3. Shi, Celine: 2 articles (05/2010 - 01/2010)
4. Shor, Boris: 2 articles (05/2010 - 01/2010)
5. Fang, Bo: 1 article (01/2016)
6. Xia, Hexia: 1 article (01/2016)
7. Zhang, Dan: 1 article (01/2016)
8. Zhang, Wei: 1 article (01/2016)
9. Follettie, Max: 1 article (05/2010)
10. Shakey, Quazi: 1 article (05/2010)

Related Diseases

1. Ovarian Neoplasms (Ovarian Cancer)
2. Neoplasms (Cancer)
3. Hypoxia (Hypoxemia)
4. Glioma (Gliomas)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Mechanistic Target of Rapamycin Complex 1
2. TOR Serine-Threonine Kinases
3. Ceramides
4. sphingosine kinase
5. Sirolimus (Rapamycin)
6. Mechanistic Target of Rapamycin Complex 2
7. temsirolimus
8. Intercellular Signaling Peptides and Proteins (Growth Factors)
9. Paclitaxel (Taxol)
10. Biomarkers (Surrogate Marker)

Related Therapies and Procedures

1. Therapeutics
2. Oral Administration